3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Dermatologic
1
Conditions
Melanoma
6
Diarrhea
2
Colitis
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Non Small Cell Lung Cancer Metastatic
1
Lung Neoplasms
1
Kidney Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
aldesleukin
15
pembrolizumab
11
Cyclophosphamide
9
fludarabine phosphate
7
fludarabine
6
Nivolumab
6
Interleukin-2
6
atezolizumab
5
Radiotherapy
5
Ipilimumab
4
Interferon-alpha
4
Drug Therapy
4
Blood Specimen Collection
4
Radiosurgery
3
tremelimumab
2
temsirolimus
2
durvalumab
2
cemiplimab
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Paclitaxel
2
Metformin
2
Interleukin-12 Subunit p35
2
Genistein
2
Gene Expression Profiling
2
Flow Cytometry
2
Filgrastim
2
Cetuximab
2
zanolimumab
1
vivitrol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Fecal Microbiota Transplantation
×
Dermatologic
×
Clear all
NCT06206707
2025-11-17
Immunobiome
University of Aarhus
Phase NA
Recruiting
20 enrolled